Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Mallinckrodt
Express Scripts
Colorcon
Baxter

Last Updated: January 27, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Betadex


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Betadex?

Betadex is an investigational drug.

There have been 11 clinical trials for Betadex. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2016.

The most common disease conditions in clinical trials are Niemann-Pick Diseases, Niemann-Pick Disease, Type C, and Niemann-Pick Disease, Type A. The leading clinical trial sponsors are Bayer, Mandos LLC, and Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company.

There are five hundred and eighty-two US patents protecting this investigational drug and twelve international patents.

Recent Clinical Trials for Betadex
TitleSponsorPhase
Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Meal on JNJ-64530440Janssen Research & Development, LLCPhase 1
Niemann-Pick Type C Treatment With Adrabetadex for Symptoms of Brain and Nervous SystemMandos LLCPhase 3
Niemann-Pick Type C Treatment With Adrabetadex for Symptoms of Brain and Nervous SystemVtesse, Inc., a Mallinckrodt Pharmaceuticals CompanyPhase 3

See all Betadex clinical trials

Clinical Trial Summary for Betadex

Top disease conditions for Betadex
Top clinical trial sponsors for Betadex

See all Betadex clinical trials

US Patents for Betadex

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Betadex ⤷  Try it Free Antifungal compound process Mycovia Pharmaceuticals, Inc. (Durham, NC) U.S. Department of Health and Human Services (Washington, DC) ⤷  Try it Free
Betadex ⤷  Try it Free Pharmaceutical composition for preventing or treating skin cancer comprising Panax spp. plant extract and method of preventing or treating skin cancer in a subject using the same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (Seoul, KR) ⤷  Try it Free
Betadex ⤷  Try it Free Low, immune enhancing, dose mtor inhibitors and uses thereof Novartis AG (Basel, CH) ⤷  Try it Free
Betadex ⤷  Try it Free Neprilysin inhibitors THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) ⤷  Try it Free
Betadex ⤷  Try it Free Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer Capella Therapeutics, Inc. (San Diego, CA) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Betadex

Drugname Country Document Number Estimated Expiration Related US Patent
Betadex Australia AU2015231234 2034-03-19 ⤷  Try it Free
Betadex Canada CA2942972 2034-03-19 ⤷  Try it Free
Betadex European Patent Office EP3119755 2034-03-19 ⤷  Try it Free
Betadex Japan JP2017509646 2034-03-19 ⤷  Try it Free
Betadex World Intellectual Property Organization (WIPO) WO2015143180 2034-03-19 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Mallinckrodt
Express Scripts
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.